BioCentury
ARTICLE | Company News

SomaLogic, NEC deal

November 3, 2014 8:00 AM UTC

SomaLogic granted NEC exclusive rights in Japan to commercialize SomaLogic's SOMAscan proteomic assay. SOMAscan uses slow off-rate modified aptamers to detect and measure 1,129 protein concentrations in different biological sample types, including blood and tissue. NEC has launched the assay. The partners declined to disclose financial terms. ...